Drugs / IW001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01199887 | Sep 2010 → Oct 2012 | idiopathic pulmonary fibrosis | ImmuneWorks | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IW001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01199887 ↗ |
| Action | Inhibit | “Thus, IW001 may produce selective suppression of immune responses against Col (V).” NCT01199887 ↗ |
| Route | Oral | “IW001 is taken orally” NCT01199887 ↗ |